BECTON DICKINSON & CO — Director's Dealing 2018

Jun 5, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BECTON DICKINSON & CO (BDX)
CIK: 0000010795
Period of Report: 2018-06-01

Reporting Person: Kaltenbach Patrick (EVP & Pres Life Sciences)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-06-01	Common Stock	A	2533	—	Acquired	2533	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-06-01	Stock Appreciation Rights	$224.94	A	22923	Acquired	2028-06-01	Common Stock (22923)	Direct

Footnotes

F1: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.

F2: The stock appreciation rights vest in four annual installments beginning June 1, 2019.